Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PH-797804 in moderate to severe COPD
NCT01321463Phase 2Completed
- Sponsor
- Pfizer
- Start
- May 2011
- Primary completion
- Jun 2012
- Modality
- Classical Binding Small Molecules
- Countries
- 15
01
Overview
Phase 2, randomised, double-blind trial in chronic obstructive pulmonary disease (COPD) comparing PH-797804 with Placebo (2 arms). Primary endpoint: Spirometry measures. Started May 2011; status: completed.
02
Drugs
PH-797804
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT01321463.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01321463.